Nootropic peptides and 'motivation without stimulants': what the science says

What did @carolinecitelli actually say?

The creator says she uses a combined semax and selank blend via injection, and that it was the first peptide where she noticed real effects, specifically "more motivation and just discipline and drive to get things done." She has ADHD but avoids stimulants because they worsen her anxiety and cause crashes. She also credits the blend with mood support, which she says was a major selling point given her dual diagnosis.

To her credit, she closes with a reasonable caution: don't buy peptides from "some random on the internet." That's actually good advice. The rest of the claims, however, deserve a closer look.

Does the science back this up?

There is legitimate preclinical and some human research on both peptides, but calling it robust would be generous. The evidence is real but thin, mostly Russian in origin, and not replicated widely in Western clinical trials.

Semax is a synthetic analog of ACTH(4-7) developed in Russia. It has shown neuroprotective and cognitive effects in animal models, and a handful of small human studies, including work by Levitskaya et al. (2008, Rossiiskii Fiziologicheskii Zhurnal), suggest it may influence dopaminergic and serotonergic pathways. That mechanistic link to motivation and focus is plausible, not proven. Selank is a synthetic analog of tuftsin with anxiolytic properties studied primarily in Russian clinical settings. Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine) found selank reduced anxiety in patients with generalized anxiety disorder without sedation. That aligns with what she describes as avoiding the stimulant "crash." The combination has logic behind it. The evidence base is just not deep enough to make confident claims.

What did they get wrong (or right)?

She gets the general mechanism directionally right. Semax does appear to modulate dopamine-related pathways, which is why a motivation effect is biologically plausible for someone with ADHD. Selank does have anxiolytic properties without classic sedation, so the framing of "motivation without stimulant feelings" is not invented.

What she gets wrong is the confidence level. Saying "I think it's 100% worth it" after describing subjective feelings of motivation is anecdote dressed as evidence. She never mentions that neither peptide is FDA-approved, that injectable peptides carry real infection risk, or that self-diagnosing ADHD management with unregulated compounds is a medically significant decision. The claim that mood support is a known benefit skips over the fact that most supporting data comes from small, non-randomized studies in specific clinical populations, not healthy pilates instructors with self-reported ADHD.

• What she got right: the mechanistic logic for both peptides is grounded in real pharmacology.
• What she got wrong: framing personal experience as reliable efficacy data for a medical condition.
• What she omitted: regulatory status, injection safety, and the absence of long-term human data.

What should you actually know?

Semax and selank are not approved by the FDA. They exist in a regulatory gray zone in the U.S., often sold as research chemicals or compounded by specialty pharmacies. If you are managing ADHD and anxiety, combining unregulated injectable peptides without medical supervision is not a low-stakes decision.

The injection route she describes matters. Injectable peptides bypass the gut but introduce infection risk, sterility concerns, and dosing variability that oral or nasal routes do not. Semax is actually studied as a nasal spray in its Russian clinical applications, not as an injection. The switch to injectable form changes the pharmacokinetic profile in ways that are not well-documented in available literature.

Her point about sourcing is valid. Peptide purity and sterility vary enormously across suppliers. Third-party testing and a licensed prescriber are not optional extras for injectable compounds. If you are interested in peptide therapy, a regulated telehealth provider with licensed clinicians and pharmaceutical-grade sourcing is the appropriate starting point, not a TikTok recommendation.